[31] In addition, the phosphorylation of PKM2Y105 by FGFR1 switches the formation of active, tetrameric PKM2 to less active, dimeric PKM2, and confers a metabolic advantage towards tumor proliferation. This evidence concerns the gene FGFR1 and neoplasm.